Endometrial Cancer

This overview addresses Endometrial Cancer, a common gynecological malignancy that begins in the lining of the uterus, often linked to hormonal imbalances, metabolic dysfunction, and prolonged estrogen exposure. It explores risk factors such as obesity, insulin resistance, age, and reproductive history, while also highlighting symptoms like abnormal uterine bleeding and pelvic discomfort. Alongside conventional diagnostics and treatments, integrative and regenerative approaches are introduced to support healing, immune defense, and hormonal balance. These include Autologous Active Specific Immunotherapy (AASI), Mito Organelles (MO), Nano Organo Peptides (NOPs), LABRMS Longevity & Vitality Formula, and other complementary therapies that help improve systemic resilience and promote cellular renewal. This resource is intended for healthcare professionals and individuals seeking a holistic perspective on managing and supporting recovery from endometrial cancer.